Ipilimumab in cancer patients: the issue of early metabolic response

被引：6
作者：
Chargari, Cyrus [1 ]
Le Moulec, Sylvestre [1 ]
Bonardel, Gerald [2 ]
Foehrenbach, Herve [2 ]
Vedrine, Lionel [1 ]
机构：
[1] Mil Val de Grace Hosp, Dept Med & Radiat Oncol, F-75005 Paris, France
[2] Mil Val de Grace Hosp, Dept Nucl Med, F-75005 Paris, France
来源：
ANTI-CANCER DRUGS | 2013年 / 24卷 / 03期
关键词：
ADVANCED MELANOMA; CTLA4; BLOCKADE;
D O I：
10.1097/CAD.0b013e32835dbaaf
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：324 / 326
页数：3
相关论文
共 8 条
  • [1] Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro
    Deichen, JT
    Prante, O
    Gack, M
    Schmiedehausen, K
    Kuwert, T
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (02) : 267 - 273
  • [2] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) : 711 - 723
  • [3] Marked, Homogeneous, and Early [18F]Fluorodeoxyglucose-Positron Emission Tomography Responses to Vemurafenib in BRAF-Mutant Advanced Melanoma
    McArthur, Grant A.
    Puzanov, Igor
    Amaravadi, Ravi
    Ribas, Antoni
    Chapman, Paul
    Kim, Kevin B.
    Sosman, Jeffrey A.
    Lee, Richard J.
    Nolop, Keith
    Flaherty, Keith T.
    Callahan, Jason
    Hicks, Rodney J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1628 - 1634
  • [4] Imaging of CTLA4 Blockade-Induced Cell Replication with 18F-FLT PET in Patients with Advanced Melanoma Treated with Tremelimumab
    Ribas, Antoni
    Benz, Matthias R.
    Allen-Auerbach, Martin S.
    Radu, Caius
    Chmielowski, Bartosz
    Seja, Elizabeth
    Williams, John L.
    Gomez-Navarro, Jesus
    McCarthy, Timothy
    Czernin, Johannes
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (03) : 340 - 346
  • [5] Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade
    Ribas, Antoni
    Comin-Anduix, Begona
    Economou, James S.
    Donahue, Timothy R.
    de la Rocha, Pilar
    Morris, Lilah F.
    Jalil, Jason
    Dissette, Vivian B.
    Shintaku, Itsushi Peter
    Glaspy, John A.
    Gomez-Navarro, Jesus
    Cochran, Alistair J.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (01) : 390 - 399
  • [6] Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
    Robert, Caroline
    Thomas, Luc
    Bondarenko, Igor
    O'Day, Steven
    Weber, Jeffrey
    Garbe, Claus
    Lebbe, Celeste
    Baurain, Jean-Francois
    Testori, Alessandro
    Grob, Jean-Jacques
    Davidson, Neville
    Richards, Jon
    Maio, Michele
    Hauschild, Axel
    Miller, Wilson H., Jr.
    Gascon, Pere
    Lotem, Michal
    Harmankaya, Kaan
    Ibrahim, Ramy
    Francis, Stephen
    Chen, Tai-Tsang
    Humphrey, Rachel
    Hoos, Axel
    Wolchok, Jedd D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2517 - 2526
  • [7] Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
    Weber, Jeffrey S.
    Kaehler, Katharina C.
    Hauschild, Axel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2691 - 2697
  • [8] Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
    Wolchok, Jedd D.
    Hoos, Axel
    O'Day, Steven
    Weber, Jeffrey S.
    Hamid, Omid
    Lebbe, Celeste
    Maio, Michele
    Binder, Michael
    Bohnsack, Oliver
    Nichol, Geoffrey
    Humphrey, Rachel
    Hodi, F. Stephen
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (23) : 7412 - 7420
1